| Name | Title | Contact Details |
|---|
Osiris Therapeutics, Inc. is a leading stem cell company focused on developing and marketing products to treat medical conditions in the inflammatory, autoimmune, orthopedic and cardiovascular areas. Osiris’ stem cell products have significant therapeutic potential because of their ability to regulate inflammation, promote tissue regeneration and prevent pathological scar formation. In Biosurgery, we harness the ability of cells and novel constructs to promote the body`s natural healing. The goals are to improve surgical outcomes and offer better treatment options for patients and physicians. We like a challenge, so the focus is in areas where we believe we can have a significant impact. Difficult indications and challenging cases are targeted. Osiris has been studying tissue engineering since the beginning, and its dedicated team conducted groundbreaking research in the field. The work in bone led to the development of the successful product Osteocel, now owned by NuVasive Inc. Now, application of these technologies is being expanded beyond bone, to soft tissues, such as cartilage and tendon, and also wound healing.
Bio-Medical Devices is a Irvine, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Mid-Atlantic Imaging Services is a Columbia, MD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
MCD is a Augusta, ME-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
U.M.G. is a Harrison, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.